Gary Liska, with Alere Home Monitoring Inc, says Alere's commitment to patients' safety is why they supported the STABLE study.
Gary Liska, with Alere Home Monitoring Inc, says Alere’s commitment to patient safety is why they supported the STABLE study. They saw an opportunity with Medicare’s expansion of its coverage policy for self-testing, and decided to provide self-testing services to Medicare and practitioners.
Mr Liska also explains why the STABLE study results are so important.
“Within the last 3 years, there have been 5 clinical papers written on cost-effectiveness. The market remains very volatile right now, and clinicians, and particularly healthcare, is looking for the most cost-effective agent,” Mr Liska says. “The 5 studies that have been published are all consistent with a certain threshold of warfarin quality of between 65% and 73%, so those are thresholds that Alere looks at very carefully. It was really the impetus behind conducting this study.”
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More